FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40857311000001101: Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2375171000001114 Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2375181000001111 Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Has AMP Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Is a Zolmitriptan 2.5mg tablets 12 tablet true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 12 tablet 2 x 6 tablets Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start